Easy Access and Express Report Delivery Service
Highlights The global Anti-allergic Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029. Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20. Report Scope This report aims to provide a comprehensive presentation of the global market for Anti-allergic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-allergic Drugs. The Anti-allergic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-allergic Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Anti-allergic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Anti-allergic Drugs by Type 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) 1.2.2 Oral Drugs 1.2.3 Non-Oral Drugs 2.3 Anti-allergic Drugs by Sales Channel 2.3.1 Market Value Comparison by Sales Channel (2018 VS 2022 VS 2029) 2.3.2 Online 2.3.3 Offline 2.4 Assumptions and Limitations 3 Anti-allergic Drugs Breakdown Data by Type 3.1 Global Anti-allergic Drugs Historic Market Size by Type (2018-2023) 3.2 Global Anti-allergic Drugs Forecasted Market Size by Type (2023-2028) 4 Anti-allergic Drugs Breakdown Data by Sales Channel 4.1 Global Anti-allergic Drugs Historic Market Size by Sales Channel (2018-2023) 4.2 Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2018-2023) 5 Global Growth Trends 5.1 Global Anti-allergic Drugs Market Perspective (2018-2029) 5.2 Global Anti-allergic Drugs Growth Trends by Region 5.2.1 Global Anti-allergic Drugs Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Anti-allergic Drugs Historic Market Size by Region (2018-2023) 5.2.3 Anti-allergic Drugs Forecasted Market Size by Region (2024-2029) 5.3 Anti-allergic Drugs Market Dynamics 5.3.1 Anti-allergic Drugs Industry Trends 5.3.2 Anti-allergic Drugs Market Drivers 5.3.3 Anti-allergic Drugs Market Challenges 5.3.4 Anti-allergic Drugs Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Anti-allergic Drugs Players by Revenue 6.1.1 Global Top Anti-allergic Drugs Players by Revenue (2018-2023) 6.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2018-2023) 6.2 Global Anti-allergic Drugs Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Anti-allergic Drugs Head office and Area Served 6.4 Global Anti-allergic Drugs Players, Product Type & Application 6.5 Global Anti-allergic Drugs Players, Date of Enter into This Industry 6.6 Global Anti-allergic Drugs Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Anti-allergic Drugs Market Size (2018-2029) 7.2 North America Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Anti-allergic Drugs Market Size by Country (2018-2023) 7.4 North America Anti-allergic Drugs Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Anti-allergic Drugs Market Size (2018-2029) 8.2 Europe Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Anti-allergic Drugs Market Size by Country (2018-2023) 8.4 Europe Anti-allergic Drugs Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Anti-allergic Drugs Market Size (2018-2029) 9.2 Asia-Pacific Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Anti-allergic Drugs Market Size by Country (2018-2023) 9.4 Asia-Pacific Anti-allergic Drugs Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Anti-allergic Drugs Market Size (2018-2029) 10.2 Latin America Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Anti-allergic Drugs Market Size by Country (2018-2023) 10.4 Latin America Anti-allergic Drugs Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Anti-allergic Drugs Market Size (2018-2029) 11.2 Middle East & Africa Anti-allergic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Anti-allergic Drugs Market Size by Country (2018-2023) 11.4 Middle East & Africa Anti-allergic Drugs Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 Sanofi 11.1.1 Sanofi Company Detail 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Anti-allergic Drugs Introduction 11.1.4 Sanofi Revenue in Anti-allergic Drugs Business (2017-2022) 11.1.5 Sanofi Recent Development 11.2 Johnson And Johnson 11.2.1 Johnson And Johnson Company Detail 11.2.2 Johnson And Johnson Business Overview 11.2.3 Johnson And Johnson Anti-allergic Drugs Introduction 11.2.4 Johnson And Johnson Revenue in Anti-allergic Drugs Business (2017-2022) 11.2.5 Johnson And Johnson Recent Development 11.3 Merck 11.3.1 Merck Company Detail 11.3.2 Merck Business Overview 11.3.3 Merck Anti-allergic Drugs Introduction 11.3.4 Merck Revenue in Anti-allergic Drugs Business (2017-2022) 11.3.5 Merck Recent Development 11.4 Teva 11.4.1 Teva Company Detail 11.4.2 Teva Business Overview 11.4.3 Teva Anti-allergic Drugs Introduction 11.4.4 Teva Revenue in Anti-allergic Drugs Business (2017-2022) 11.4.5 Teva Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Detail 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Anti-allergic Drugs Introduction 11.5.4 GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2017-2022) 11.5.5 GlaxoSmithKline Recent Development 11.6 Bayer 11.6.1 Bayer Company Detail 11.6.2 Bayer Business Overview 11.6.3 Bayer Anti-allergic Drugs Introduction 11.6.4 Bayer Revenue in Anti-allergic Drugs Business (2017-2022) 11.6.5 Bayer Recent Development 11.7 Sun Pharma 11.7.1 Sun Pharma Company Detail 11.7.2 Sun Pharma Business Overview 11.7.3 Sun Pharma Anti-allergic Drugs Introduction 11.7.4 Sun Pharma Revenue in Anti-allergic Drugs Business (2017-2022) 11.7.5 Sun Pharma Recent Development 11.8 UCB Pharma 11.8.1 UCB Pharma Company Detail 11.8.2 UCB Pharma Business Overview 11.8.3 UCB Pharma Anti-allergic Drugs Introduction 11.8.4 UCB Pharma Revenue in Anti-allergic Drugs Business (2017-2022) 11.8.5 UCB Pharma Recent Development 11.9 Yangtze River Pharmaceutical Group 11.9.1 Yangtze River Pharmaceutical Group Company Detail 11.9.2 Yangtze River Pharmaceutical Group Business Overview 11.9.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Introduction 11.9.4 Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2017-2022) 11.9.5 Yangtze River Pharmaceutical Group Recent Development 11.10 Hainan Poly Pharm 11.10.1 Hainan Poly Pharm Company Detail 11.10.2 Hainan Poly Pharm Business Overview 11.10.3 Hainan Poly Pharm Anti-allergic Drugs Introduction 11.10.4 Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2017-2022) 11.10.5 Hainan Poly Pharm Recent Development 11.11 Chongqing Huapont Pharmaceutical 11.11.1 Chongqing Huapont Pharmaceutical Company Detail 11.11.2 Chongqing Huapont Pharmaceutical Business Overview 11.11.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Introduction 11.11.4 Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2017-2022) 11.11.5 Chongqing Huapont Pharmaceutical Recent Development 11.12 Dawnrays 11.12.1 Dawnrays Company Detail 11.12.2 Dawnrays Business Overview 11.12.3 Dawnrays Anti-allergic Drugs Introduction 11.12.4 Dawnrays Revenue in Anti-allergic Drugs Business (2017-2022) 11.12.5 Dawnrays Recent Development 13 Report Conclusion 14 Disclaimer